Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Will Use Genetix's ClonePixFL in PD-Direct Offering

NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
 
The technology will be offered through Invitrogen's PD-Direct offering.
 
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
 
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.
 
Financial details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.